Sara Anvari

Dr. Sara Anvari

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2019 in Children
Verified
Journal Article
Open access
PDF file
HWHelen Wang
Helen Wang
SASara Anvari
Sara Anvari
KAKatherine Anagnostou
Katherine Anagnostou
The prevalence of allergic disorders has been increasing worldwide and significantly impacts the quality of life of the atopic individual. There has been an increased interest in the role of probiotics for the prevention and treatment of allergic disorders, given the recent evidence that atopy risk may be associated with a dysbiosis of the gut microbiome. Research in this area is ongoing with some studies showing possible benefits of probiotics, with seemingly little to no risk. While these studies suggest that there may be a promise in probiotic use for the prevention or treatment of allergy, further evidence is needed to determine its efficacy, optimal dosing, and strains needed for treatment. In this review, we discuss recently published studies examining the benefits, risks, and role of probiotics in preventing atopic dermatitis, asthma, allergic rhinitis, and food allergy.

26 May 2020 in Children
Verified
Journal Article
Open access
PDF file
CNChristina L. Nance
Christina L. Nance
RDRoman Deniskin
Roman Deniskin
VDVeronica C. Diaz
Veronica C. Diaz
MPMisu Paul
Misu Paul
SASara Anvari
Sara Anvari
KAKatherine Anagnostou
Katherine Anagnostou
Food allergies are common and estimated to affect 8% of children and 11% of adults in the United States. They pose a significant burden—physical, economic and social—to those affected. There is currently no available cure for food allergies. Emerging evidence suggests that the microbiome contributes to the development and manifestations of atopic disease. According to the hygiene hypothesis, children growing up with older siblings have a lower incidence of allergic disease compared with children from smaller families, due to their early exposure to microbes in the home. Research has also demonstrated that certain environmental exposures, such as a farming environment, during early life are associated with a diverse bacterial experience and reduced risk of allergic sensitization. Dysregulation in the homeostatic interaction between the host and the microbiome or gut dysbiosis appears to precede the development of food allergy, and the timing of such dysbiosis is critical. The microbiome affects food tolerance via the secretion of microbial metabolites (e.g., short chain fatty acids) and the expression of microbial cellular components. Understanding the biology of the microbiome and how it interacts with the host to maintain gut homeostasis is helpful in developing smarter therapeutic approaches. There are ongoing trials evaluating the benefits of probiotics and prebiotics, for the prevention and treatment of atopic diseases to correct the dysbiosis. However, the routine use of probiotics as an intervention for preventing allergic disease is not currently recommended. A new approach in microbial intervention is to attempt a more general modification of the gut microbiome, such as with fecal microbiota transplantation. Developing targeted bacterial therapies for food allergy may be promising for both the treatment and prevention of food allergy. Similarly, fecal microbiota transplantation is being explored as a potentially beneficial interventional approach. Overall, targeted bacterial therapies for food allergy may be promising for both the treatment and prevention of food allergy.

26 May 2022 in Frontiers in Allergy
Verified
Journal Article
Open access
SASara Anvari
Sara Anvari
MRMelanie A. Ruffner
Melanie A. Ruffner
Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE, cell-mediated food allergy, commonly diagnosed in infants and young children. In recent years, new-onset adult FPIES has been recognized. The underlying pathogenic mechanism of FPIES has yet to be elucidated, thus disease-specific diagnostic biomarkers have yet to be determined and an oral food challenge (OFC) remains the gold-standard for the diagnosis. Pediatric patients with FPIES classically present with symptoms of delayed, repetitive vomiting approximately 1 to 4 hours following ingestion of a food allergen. However, adults with FPIES have been reported to have a different symptom profile and different food triggers compared to the pediatric FPIES population. The current FPIES diagnostic criteria may not be appropriate for the diagnosis of adult FPIES patients, thus an oral food challenge remains a diagnostic tool. This review provides an overview of the current literature on the clinical presentation, epidemiology, diagnosis, triggers and management of adult FPIES.

1 August 2022 in Allergy
Verified
Journal Article
Closed access
SASara Anvari
Sara Anvari
USUpeka Samarakoon
Upeka Samarakoon
XFXiaoqing Fu
Xiaoqing Fu
JJJordan Jaggers
Jordan Jaggers
AGAlexei Gonzalez-Estrada
Alexei Gonzalez-Estrada
KBKimberly G. Blumenthal
Kimberly G. Blumenthal

4 April 2018 in Children
Verified
Journal Article
Open access
PDF file
SASara Anvari
Sara Anvari
KAKatherine Anagnostou
Katherine Anagnostou
Food allergies are on the rise and have a major impact on the quality of life of the food allergic child and their family. Currently, the mainstream treatment for food allergies is strict avoidance and elimination of the allergenic food(s) from the patient’s diet in order to prevent an allergic reaction. However, recent advances in research have presented new therapeutic options for food allergic patients that are potentially becoming promising alternatives to traditional treatment. Food immunotherapy is the most popular of these new emerging interventions and has been studied intensively over the last decade for various foods. In this review, we discuss this exciting new development that is aspiring to become part of the mainstream therapy for food allergy.

30 April 2024 in Allergy
Verified
Journal Article
Closed access
PGPurificación Gonzalez‐Delgado
Purificación Gonzalez‐Delgado
SASara Anvari
Sara Anvari
AEAna Entrala
Ana Entrala
SISonsoles Infante
Sonsoles Infante